Log In
BCIQ
Print this Print this
 

FP-020

  Manage Alerts
Collapse Summary General Information
Company Foresee Pharmaceuticals Co. Ltd.
DescriptionSelective non-hydroxamate matrix metalloproteinase 12 (MMP12) inhibitor
Molecular Target Matrix metalloproteinase 12 (MMP12)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard Indication Renal (unspecified)
Indication DetailsTreat Alport syndrome
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today